DALACIN C

Medicinal product

(Invented) name

DALACIN C

Active substance (s)

Klindamicinas

Strength

300 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G01AA10, Clindamycin

Marketing authorisation holder

UAB Ideal Trade Links, Lietuva

Date of authorisation

2023-06-21

Date of renewal

Documents

1917_DALACIN C 300mg_kiet_kaps_PZPL_2023-06-21.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra	1 vnt.
Klindamicinas	300 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111167	97278	1097278	lizdinė plokštelė	N8		Receptinis	LT/L/23/1917/001	Netiekiama	-	-	No	-	-
111168	97279	1097279	lizdinė plokštelė	N16		Receptinis	LT/L/23/1917/002	Netiekiama	-	-	No	-	-	Download
111169	97280	1097280	lizdinė plokštelė	N24		Receptinis	LT/L/23/1917/003	Netiekiama	-	-	No	-	-
111170	97281	1097281	lizdinė plokštelė	N32		Receptinis	LT/L/23/1917/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-06-21	Registruotas